Markets:

Overview

News

Currencies

International

Treasuries

Laboratory Corp American Holdings (NY:LH)

268.83 -0.28 (-0.10%)

Streaming Delayed Price Updated: 1:15 PM EST, Nov 26, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Laboratory Corp American Holdings

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

NeoGenomics (NEO) To Report Earnings Tomorrow: Here Is What To Expect

February 17, 2025

Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) will be reporting results tomorrow morning. Here’s what to look for.

Via StockStory

Labcorp Q4 Earnings: Revenue And EPS Beat, Expects Strong 2025 Growth, Analyst Reiterates Outperform On Stable 2025 Outlook ↗

February 06, 2025

Labcorp's Q4 EPS of $3.45 topped estimates, with sales rising 9.8% to $3.33 billion. 2025 guidance points to continued growth in diagnostics and biopharma.

Via Benzinga

Labcorp (NYSE:LH) Surprises With Q4 Sales, Full-Year Outlook Slightly Exceeds Expectations

February 06, 2025

Healthcare diagnostics company Labcorp Holdings (NYSE:LH) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 9.8% year on year to $3.33 billion. The company’s full-year revenue...

Via StockStory

Earnings Scheduled For February 6, 2025 ↗

February 06, 2025

Via Benzinga

Labcorp (LH) Reports Earnings Tomorrow: What To Expect

February 05, 2025

Healthcare diagnostics company Labcorp Holdings (NYSE:LH) will be reporting earnings tomorrow before the bell. Here’s what to look for.

Via StockStory

Beyond The Numbers: 6 Analysts Discuss Labcorp Holdings Stock ↗

February 03, 2025

Via Benzinga

Beyond The Numbers: 8 Analysts Discuss Labcorp Holdings Stock ↗

January 07, 2025

Via Benzinga

Analyst Expectations For Labcorp Holdings's Future ↗

December 10, 2024

Via Benzinga

Jim Cramer Says Lazard Is 'Really Inexpensive,' Recommends Buying This Tech Stock ↗

January 03, 2025

Via Benzinga

Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare ↗

November 09, 2024

Trump's second term could bring significant changes to U.S. healthcare, with cuts to ACA subsidies and potential Medicare privatization.

Via Benzinga

Topics Government

Praia Health Secures Strategic Investment from Labcorp Venture Fund, Announces New Collaboration to Streamline Patient Lab Ordering Experience

November 04, 2024

From Praia Health

Via Business Wire

Expert Outlook: Labcorp Holdings Through The Eyes Of 12 Analysts ↗

October 25, 2024

Via Benzinga

Analyst Ratings For Labcorp Holdings ↗

September 20, 2024

Via Benzinga

Analyst Expectations For Labcorp Holdings's Future ↗

August 05, 2024

Via Benzinga

LabCorp Analysts Boost Their Forecasts After Better-Than-Expected Earnings ↗

August 02, 2024

Via Benzinga

Laboratory Corp Q3 Earnings Beat Street View, Investors Overlook Hurricane Helene Impact ↗

October 24, 2024

LabCorp Q3 2024 EPS beats expectations at $3.50, with 7.4% revenue growth to $3.28B. Adjusted EPS guidance revised due to weather.

Via Benzinga

Topics Earnings

UPS Posts Upbeat Q3 Results, Joins Tesla, Celestica, Pool, T-Mobile And Other Big Stocks Moving Higher On Thursday ↗

October 24, 2024

Via Benzinga

NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S.

October 16, 2024

From NOWDiagnostics, Inc.

Via Business Wire

Labcorp Holdings Stock: A Deep Dive Into Analyst Perspectives (6 Ratings) ↗

July 08, 2024

Via Benzinga

Forecasting The Future: 4 Analyst Projections For Labcorp Holdings ↗

May 30, 2024

Via Benzinga

Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain ↗

August 26, 2024

Labcorp considers boosting its mpox testing capacity as the WHO declares a global health emergency. Companies like Roche and Quest Diagnostics are also monitoring demand and expanding testing...

Via Benzinga

DoorDash And Exact Sciences Are Among Top 10 Large Cap Gainers Last Week (July 28-Aug 3): Are The Others In Your Portfolio? ↗

August 04, 2024

Top 10 stocks with highest gains last week, including Exact Sciences, Alnylam Pharmaceuticals, Resmed, Coca-Cola Consolidated, DexCom, Sprouts Farmers Market, UL Solutions, Labcorp Holdings, C.H....

Via Benzinga

LabCorp's Stock Soars After Q2 Performance, Analyst Highlights Strong Position In Healthcare Sector ↗

August 01, 2024

LabCorp reported Q2 2024 adjusted EPS of $3.94, surpassing expectations of $3.78. Sales increased by 6.2% to $3.22 billion, driven by organic revenue growth and acquisitions. LabCorp revised its 2024...

Via Benzinga

Is This Telehealth Stock a Buy After the Recent Pullback?

July 19, 2024

Hims & Hers Health leverages telehealth's accessibility to disrupt traditional healthcare and deliver personalized wellness solutions.

Via MarketBeat

Analyst Ratings For Laboratory Corp ↗

April 26, 2024

Via Benzinga

Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX

April 30, 2024

Via AB Newswire

Intelligent Bio Solutions’ Fingerprint Drug Screening Technology Poised For Massive Growth ↗

April 25, 2024

Intelligent Bio Solutions (Nasdaq: INBS) is a medical technology company developing and commercializing innovative, intelligent, rapid, noninvasive testing solutions.

Via Talk Markets

Labcorp's Q1 Revenue Surpasses Forecasts; Analysts Scrutinize Invitae Deal ↗

April 25, 2024

Labcorp beats Q1 sales estimates, driven by organic growth and acquisitions. Revised 2024 guidance projects higher EPS and sales growth. The acquisition of Invitae is expected to bolster Labcorp's...

Via Benzinga

LH Stock Earnings: Laboratory Corp Beats EPS, Beats Revenue for Q1 2024 ↗

April 25, 2024

LH stock results show that Laboratory Corp beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Xcell Biosciences Strengthens Cell and Gene Therapy Collaboration With Labcorp

April 01, 2024

From Xcell Biosciences Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.